ISSN: 2476-2253

Journal of Cancer Diagnosis
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Cancer Diagn,

Oral Cancers: A New Perspective on Anticancer/Antioxidants

Hossein Rafiei1,2* and Maryam Rafiei3
1KROK University, Kyiv, Ukraine
2PhD in Cell and Developmental Biology, Department of Biology, Faculty of Sciences, Islamic Azad University, Tehran Science and Research Branch, Fars Campus, Shiraz, Iran
3PhD in Statistics, Department of Mathematics and Statistics, Mashhad Branch, Islamic Azad University, Mashhad, Iran
*Corresponding Author : Hossein Rafiei, PhD in Cell and Developmental Biology, Department of Biology, Faculty of Sciences, Islamic Azad University, Tehran Science and Research Branch, Fars Campus, Shiraz, Iran, Tel: +769-99077847, Email: hosraf1@gmail.com

Received Date: Mar 01, 2023 / Published Date: Mar 29, 2023

Abstract

Globally, oral cancer (OC) is one of the most prevalent malignancies with a negligible prognosis, a high recurrence rate, and high therapeutic costs. Despite many efforts to resolve these issues, no alternative definitively effective solution has yet been presented. From this point of view, it seems necessary to research other new therapeutic methods. Antioxidants are oxidation inhibitors demonstrating diverse physiological functions in the body. In this review, we focused on some compounds that, despite their antioxidant properties, have evidenced anti-cancerous effects on OCs.

Citation: Rafiei H, Rafiei M (2023) Oral Cancers: A New Perspective on Anticancer/Antioxidants. J Cancer Diagn 7: 174.

Copyright: © 2023 Rafiei H, et al. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top